Gene Silencing Hormones Marketing Pharma Companies 
Delveinsight
AUGUST 6, 2020
The Hereditary Transthyretin Amyloidosis (hATTR) Market size in the 7MM was estimated to be USD 306.9 Among the 7MM geographies, the US accounted for the 54% share of the total hATTR market size. Transthyretin (TTR) is a protein that the liver produces to facilitate the transfer of thyroid hormone and vitamin A in the blood.
pharmaphorum
DECEMBER 23, 2020
The results also suggest further uses for the drug in early disease and more revenues to come from one of the company’s biggest success stories from the last decade. Biogen and Denali will co-market the lead LRRK2 product in the US and China, and Biogen will commercialise in all other markets.
Expert insights. Personalized for you.
52 
Let's personalize your content